Line Uhrenholt

Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

René Cordtz, Jesper Lindhardsen, Bolette Gylden Soussi et al. · Lara D. Veeken · 2020 · 127 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin et al. · BMJ · 2020 · 113 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin et al. · Annals of the Rheumatic Diseases · 2023 · 52 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)

Line Uhrenholt, Annette Schlemmer, Ellen‐Margrethe Hauge et al. · BMJ Open · 2019 · 25 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study

Line Uhrenholt, Robin Christensen, Lene Dreyer et al. · Scandinavian Journal of Rheumatology · 2021 · 18 citations · Full text

Medicine, Health Informatics, Health Assessment +15